Showing 19,861 - 19,880 results of 63,912 for search '(( 50 ((greater decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 e decrease ))', query time: 1.30s Refine Results
  1. 19861

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  2. 19862

    Study 2: Impact of post-isolation delay and cell freezing. by Dione T. Kobayashi (114574)

    Published 2012
    “…<p>SMN signals were evaluated in PBMCs from 4 individuals that were analyzed with 45 minute, 2 h and 24 h delays after cell isolation. A subsample from each timepoint was frozen to assess post-freezing viability and SMN signals. …”
  3. 19863

    Presentation-1_Incorporation of Soil-Derived Covariates in Progeny Testing and Line Selection to Enhance Genomic Prediction Accuracy in Soybean Breeding.zip by Caio Canella Vieira (11928644)

    Published 2022
    “…Four statistical models were considered, including the GBLUP model (M1), the reaction norm model (M2) including the interaction between molecular markers and the environment (G×E), an extended version of M2 that also includes soil type (S), and the interaction between soil type and molecular markers (G×S) (M3), and a parsimonious version of M3 which discards the G×E term (M4). …”
  4. 19864

    Kinetic properties of TPH2 variants are modulated by RNA editing. by Maik Grohmann (253878)

    Published 2010
    “…(C, D) Double reciprocal Lineweaver-Burk plots for <i>K<sub>m</sub></i>(W) determination of TPH2 variants. Enzymatic activities of TPH2A and TPH2B, and TPH2A 1234 and TPH2B 234 isoforms were similar, respectively, when using the synthetic cofactor 6MPH4. …”
  5. 19865
  6. 19866
  7. 19867

    NADPH oxidation and H<sub>2</sub>O<sub>2</sub> production by Bs3 and Bs3<sub>S211A</sub>. by Christina Krönauer (11301989)

    Published 2021
    “…NADPH oxidation was monitored via decrease of absorbance at 340 nm. Yucasin and methimazole (MMI) were dissolved in DMSO and added at a final concentration of 50 μM. …”
  8. 19868

    <i>Arabidopsis</i> H2B.3 is preferentially expressed in non-dividing cells. by Danhua Jiang (197054)

    Published 2020
    “…<p>(A) Relative expression of <i>Arabidopsis</i> somatic H2Bs in the shoot apex, young leaf and mature leaf, which represent tissue with decreasing mitotic activity from shoot apex to mature leaf. …”
  9. 19869
  10. 19870

    Data_Sheet_2_Influence of CO2 Degassing on the Microbial Community in a Dry Mofette Field in Hartoušov, Czech Republic (Western Eger Rift).CSV by Qi Liu (33068)

    Published 2018
    “…The abundance of microbes did not show a typical decrease with depth, indicating that the uprising CO<sub>2</sub>-rich fluid provides sufficient substrate for chemolithoautotrophic anaerobic microorganisms. …”
  11. 19871

    Nkx1.2 mediates FGF-dependent FP competence. by Noriaki Sasai (217813)

    Published 2014
    “…[i] explants were collected without incubation (i) or after a 12-h incubation (ii–iv) with the control medium (ii), with 4 nM Shh (iii), or with 5 nM FGF (iv), and the expression of Nkx1.2 was assayed by qRT-PCR. …”
  12. 19872
  13. 19873

    PoRVA G9P[23] strain and PoRVA G5P[7] strain infection differentially affect PEDV-induced cellular metabolic reprogramming. by Haixin Liu (7571234)

    Published 2024
    “…<p><b>(A)</b> Schematic diagram of the global metabolic profiling experimental design. IPEC-J2 cells in the PEDV group were first incubated in DMEM for 12 h and then inoculated with PEDV (MOI = 1) for another 12 h. …”
  14. 19874

    CK1δ NP increases Per2 degradation. by Gracie Wee Ling Eng (4031528)

    Published 2017
    “…Because PER2 half-life plateaus at 30% of control, the half maximal decrease occurs at 65% of control. …”
  15. 19875
  16. 19876

    Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  17. 19877

    Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  18. 19878

    Crystal Structure of YbCu<sub>6</sub>In<sub>6</sub> and Mixed Valence Behavior of Yb in YbCu<sub>6–<i>x</i></sub>In<sub>6+<i>x</i></sub> (<i>x</i> = 0, 1, and 2) Solid Solution by Udumula Subbarao (1431364)

    Published 2016
    “…A deviation in inverse susceptibility data at 200 K suggests a valence transition from Yb<sup>2+</sup> to Yb<sup>3+</sup> as the temperature decreases. …”
  19. 19879

    Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  20. 19880

    Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”